The story of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, generating billions in revenue , its patent expiration created a wave of knock-off medications, significantly eroding its dominance. While certain businesses may try to capitalize on similar conditions , the present landscape de